D3 BIO
LIVE

Serial Number

90662885

Owner

D3 Bio (Wuxi) Co., Ltd.

Attorney

John Paul Oleksiuk

Filing Date

Apr 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

D3 BIO Trademark

Serial Number: 90662885 • Registration: 7830854

D3 BIO is a trademark filed by D3 Bio (Wuxi) Co., Ltd. on April 22, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

D3 Bio (Wuxi) Co., Ltd. (4 trademarks)

324 No. 88 Mei Liang Road
Jiangsu Province 214100 , CN

Entity Type: 99

Trademark Details

Filing Date

April 22, 2021

Registration Date

June 17, 2025

Published for Opposition

April 29, 2025

Goods & Services

Pharmaceutical preparations for the treatment of respiratory diseases, cancer, musculoskeletal diseases, gastrointestinal disease, diseases and disorders related to the immune system, central nervous system, and cardiovascular system; chemico-pharmaceutical preparations for the treatment of respiratory diseases, cancer, musculoskeletal diseases, gastrointestinal disease, diseases and disorders related to the immune system, central nervous system, and cardiovascular system; drugs for medical purposes; pharmaceutical preparations for use in biomedicine; pharmaceutical drugs for the treatment of respiratory diseases; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparation for treating musculoskeletal disorders; pharmaceutical preparation for treating gastrointestinal disease; pharmaceutical preparation for treating diseases and disorders related to the immune system; pharmaceutical preparation for the central nervous system; cardiovascular pharmaceutical drug preparation; none of the foregoing related to diagnostic preparations, diagnostic reagents, or diagnostic screening kits

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 17, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 17, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 23, 2025 NONP
EXPARTE APPEAL TERMINATED
Apr 1, 2025 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 31, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 31, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 31, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 31, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 14, 2024 ERFR
EX PARTE APPEAL-INSTITUTED
Oct 14, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Oct 14, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Oct 14, 2024 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 29, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 29, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 29, 2024 GNFN
FINAL REFUSAL E-MAILED
Apr 29, 2024 GNFR
FINAL REFUSAL WRITTEN
Apr 29, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2022 CRFA
ASSIGNED TO LIE
Jul 23, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 5, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 5, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 5, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 5, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 17, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 29, 2021 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2021 NWOS
NEW APPLICATION ENTERED
Apr 26, 2021 NWAP